Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
250
-
Total shares
-
3.42M
-
Shares change
-
+261K
-
Total reported value, excl. options
-
$569M
-
Value change
-
+$43M
-
Number of buys
-
99
-
Number of sells
-
-106
-
Price
-
$166.21
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2024
280 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2024.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.42M shares
.
Largest 10 shareholders include MORGAN STANLEY (425K shares), BANK OF AMERICA CORP /DE/ (219K shares), UBS Group AG (194K shares), WELLS FARGO & COMPANY/MN (190K shares), LPL Financial LLC (187K shares), RAYMOND JAMES FINANCIAL INC (167K shares), Berger Financial Group, Inc (154K shares), Royal Bank of Canada (154K shares), ENVESTNET ASSET MANAGEMENT INC (114K shares), and Csenge Advisory Group (51.7K shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.